Description:
Oragenics, Inc. is a biotechnology company based in Tampa, Florida, focused on developing groundbreaking therapies and antibiotics to combat infectious diseases, particularly those driven by antibiotic-resistant pathogens. Utilizing its proprietary technologies, the company aims to deliver novel drug candidates addressing critical healthcare needs. With a commitment to public health enhancement, Oragenics is actively expanding its therapeutic pipeline through strategic partnerships and research initiatives, establishing itself as a significant contributor to the global battle against infectious diseases while improving treatment landscapes for patients.
Address:
1990 MAIN STREET, SARASOTA, FL, UNITED STATES, 34236
Fiscal year end:
December
Market capitalization:
$3.46 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-100%
How much will you get:
$0
Prices dates:
31-12-2015: $27,000.00 and 31-12-2025: $0.78